Get Adobe Flash player

АСОЦІАЦІЯ АЛЕЛЬНИХ ПОЛІМОРФІЗМІВ ГЕНУ ЕНДОТЕЛІАЛЬНОЇ NO-СИНТАЗИ З РОЗВИТКОМ ІШЕМІЧНОЇ ХВОРОБИ СЕРЦЯ (ЛІТЕРАТУРНИЙ ОГЛЯД)

Автор: Приступа Л.Н., Погорєлова О.С.

Сторінки: 375-386

Анотація

         

Проведений аналіз вітчизняних та закордонних досліджень стосовно вивчення впливу Т-786С, G894T, 4a/b поліморфізмів гену eNOS на ризик розвитку ІХС у представників різних популяцій. Доведена роль Т-786 С поліморфізма гену eNOS у розвитку ІХС у представників японської, української, італійської популяції, причому в останніх він пов’язаний із багатосудинним ураженням. G894T поліморфізм гену eNOS пов’язаний із підвищеним ризиком розвитку ІХС, ішемічних інсультів в італійській, турецькій, азіатській  популяціях, а в російській ─ із рестенозами стентів. Доведений зв’язок 4а/4b поліморфізму гену eNOS із виникненням ІХС у турецькій, японській, корейській,  афро-американській, іранській, російській  популяціях, а в японській популяції  ─  гендерна специфіка даної асоціації. В окремих дослідженнях отримані суперечливі дані щодо впливу Т-786 С поліморфізму гену eNOS в турецькій популяції. Не виявлено асоціації 4а/4b поліморфізму гену eNOS у чоловіків Словенії, Фінляндії,  G894T поліморфізму гену eNOS у корейській популяції, а у представників білої австралійської популяцій не виявлено асоціації генотипів 4а/4b, G894T, Т-786С поліморфізму гену eNOS із ризиком розвитку ІХС.

Ключові слова: хронічне обструктивне захворювання легень, ішемічна хвороба серця, поліморфізм гена ендотеліальної синтази оксиду азоту.

Ця електронна адреса захищена від спам-ботів. вам потрібно увімкнути JavaScript, щоб побачити її.

Список літератури

1. Ahmineeva AH, Polunina OS, Voronina LP et al. [Funktsionalnoe sostoyanie sosudistogo endoteliya pri ishemicheskoy bolezni serdtsa]. Sovremennyie naukoemkie tehnologii. 2013;4:106.
2. Alp E, Menevse S, Tulmac M et al. Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population. DNA Cell Biol. 2009;28(7):343-350.
3. Alvarez R, Gonzalez P, Batalla A et al. Association between the NOS3 (−786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. NitricOxide. 2001;5:343–348.
4. Andrikopoulos GK, Grammatopoulos DK, Tzeis SE, Zervou SI Association of the 894G>T polymorphism in the endothelial nitric oxide synthase gene with risk of acute myocardial infarction. BMC Med. Genet. 2008;21;39-43.
5. Antsiferova EV, Nikulina SYu, Emelyanchik EYu [Osobennosti polimorfizma endogennoy NO- sintazyi u detey s idiopaticheskim sindromom slabosti sinusovogo uzla]. Lechaschiy vrach. 2013;10:55.
6. Augeri AL, Tsongalis GJ, Van Heest JL et al.The endothelial nitric oxide synthase -786 T>C polymorphism and the exercise-induced blood pressure and nitric oxide responses among men with elevated blood pressure. Atherosclerosis. 2009;204(2):e28-34.
7. Balatskiy AV [Polimorfizm genov endotelialnoy NO-sintazyi i konneksina-37 kak faktor riska razvitiya infarkta miokarda u lits bez koronarnogo anamneza]. Terapevticheskiy arhiv. 2013;9:18-22.
8. Cam SF, Sekuri C, Tengiz I et al. The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb. Res. 2005;116(4):287-292.
9. Casas JP, Bautista LE, Humphries SE, Hingorani AD Endothelial nitric oxide synthase genotype and ischemic heart disease: Meta-analysis of 26 studies involving 23028 subjects. Circulation. 2004;109:1359-1365.
10. Cattaruzza M, Guzik TJ, Slodowski W et al. Shear stress intensitivity of endothelial nitric oxide synthase expressionas genetic risk factor for coronary heart disease. Circurat. Res. 2004;95:841-847.
11. Сiftсi C, Melil S, Сebi Y et al. Association of endothelial nitric oxide synthase promoter region (T-786C) gene polymorphism with acute coronary syndrome and coronary heart disease. Lipids in Health and Disease. 2008;2:5-7.
12. Cinzia F, Francesco S, Sticchietal E Influence of endothelial nitricoxidesynthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. American heart journal. 2004; 147(3):516–521.
13. Colombo MG, Paradossi U, Andreassi MG et al. Endothelial nitric oxide synthase gene polymorphisms and risk of coronaryarterydisease. Clin. Chem. 2003;49(3):389–395.
14. Dosenko VE, Lutay YaM, Zagoriy VYu et al. [Chastota allelnogo polimorfizma gena endotelialnoy NO-sintazyi u bolnyih s ostryim koronarnyim sindromom v ukrainskoy populyatsii]. Tsitologiya i genetika. 2005;39(2):49-54.
15. Dosenko VE, ZagorIy VYu, Moybenko OO [PatofIzIologIchnI aspekti genetichnogo polImorfIzmu endotelIalnoYiNO-sintazi]. FIzIol. zhurn. 2003;48(6):86-102.
16. Dosenko VE, ZagorIy VYu, Haytovich NV [Alelniy polImorfIzm genuendotelIalnoYiNO-sintazi ta yogo funktsIonalnI proyavi]. FIzIol. zhurn. 2005;51(2):39-45.
17. DosenkoVE [Rol alelnogo polImorfIzmu genIv endotelIalnoYi NO-sintazi ta proteasomi v patogenezI sertsevo-sudinnih zahvoryuvan: molekulyarno-genetichnIaspekti]. – Rukopis. DisertatsIya na zdobuttya naukovogo stupenya doktora medichnih nauk za spetsIalnIstyu 14.03.04 – patologIchna fIzIologIya. – Institut fIzIologii im. O.O.Bogomoltsya NAN UkraYini, Kiyiv, 2006.
18. Ekmekçi A, Ozcan KS, Güngör B et al. The relationship between endothelial nitric oxide synthase 4a/4b gene polymorphism and premature coronary artery disease. Acta Cardiol. 2013;68(5):464-468.
19. Fatini C, Sofi F, Sticchi E et al. Influence of endothelial nitric oxide gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J. 2004;147(3):516-521.
20. Förstermann U, Boissel JP, Kleinert H Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 1998;12(10):773-90.
21. Ghilardi G, Biondi ML, DeMonti M et al. Independent risk factor for moderate to severe internal carotid arterystenosis: T786C mutation of endothelial nitric oxide synthase gene. Clin. Chem. 2002;48(7):989–993.
22. Golser R, Gorren ACF, Mayer B et al. Functional characteristic of Glu298Asp mutant human endothelial nitric oxide synthase purified from a yeast expression system. Nitric Oxide. 2003;8:7-14.
23. Gomma AH, Elrayess MA, Knight CJ et al. The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis. Eur Heart J. 2002; 23:1955-1962.
24. Hooper WC, Lally C, Austin H et al. The relationship between polymor-phism in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism on African Americans. Chest. 1999;116:880-6.
25. Hyndman ME, Parsons HG, Verma S et al. The T-786C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension. 2002;39(4): 919–922.
26. Cruz-González I, Corral E, Sánchez-Ledesma M et al. Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study. BMC Cardiovasc Disord 2009;4:29-35.
27. In Jai Kim, Jeehyeon B, Sang WL et al. Influence of endothelial nitric oxide synthase gene polymorphisms (−786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease. Trombosis research. 2007;119(5):579–585.
28. Jeerooburkhan N, Jones LC, Bujac S et al. Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease. Hypertension. 2001;38(5):1054-61.
29. Li J, Wu X, Li X et al The endothelial nitricoxide synthase gene asassociated with coronary artery disease: a meta-analysis. Cardiology. 2010;116(4):271-8.
30. Li YY Endothelial nitric oxide synthase G894T gene polymorphism and essential hypertension in the Chinese population: a meta-analysis involving 11,248 subjects. Intern. Med. 2011;50(19):2099-2106.
31. Liu D, Jiang Z, Dai L et al. Association between the - 786T>C 1polymorphism in the promoter region of endothelial nitric oxide synthase (eNOS) and risk of coronary artery disease: a systematic review and meta-analysis. Gene. 2014;545(1):175-83
32. Malahov VA, Zavgorodnyay N, Lyichko VS [Problema oksida azota v nevrologii] MonografIya. – Sumyi: izdatelstvo SumGPU im. A.S. Makarenko, 2009. – 242.
33. Markus HS, Ruigrok Y, Ali N, Powell JF Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke. 1998;29(9):1908-11.
34. Marsden PA, Schappert KT, Chen HS et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 1992;307:287-293.
35. Melchers I, Cattaruzza M A gene defect in the promoter of the endothelial NO synthase as a risk factor for rheumatoid arthritis Z. Rheumatol. 2007;66(4):326-327.
36. Milutinović A, Hruskovicova H The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Slovene men (Caucasians). Folia Biol (Praha). 2005;51(2):47-9.
37. Motoyama T, Kawano H, Kugiyama K et al. Endothelium-dependent vasodilation in the brachial arteryis impaired in smokers: effect of vitamin C. Am. J. Physiol. 1997;273(4 Pt 2): H1644–1650.
38. Munshi A, Rajeshwar K, Kaul S, Chandana E VNTR polymorphism in intron 4 of the eNOS gene and the risk of ischemic stroke in a South Indian population. Brain Res Bull. 2010;82(5-6):247-50.
39. Nakayama M, Yasue H, Yoshimura M et al. T(-786)C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis]. Am. J. Cardiol. 2000;86(6):628–634.
40. Nakayama M, Yoshimura M, Sakamoto T et al.
Synergistic interaction of T-786-->C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm. Pharmacogenetics. 2003;13(11):683-688.
41. Nidiane C. Martinelli, Kátia G. Santos, Andréia Biolo et al. Polymorphisms of endothelial nitric oxide synthase gene in systolic heart failure: An haplotype analysis NitriceOxide. 2012;26(3):141–147.
42. Paradossi U, Ciofini E, Clerico A et al. Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298-->Asp and T-786-->C polymorphisms. Stroke. 2004;35(6):1305-1309.
43. Parhomenko AN, Kozhuhov SN, Lutay YaM, Moybenko AA [Polimorfizm T-786C promotora gena endotelialnoy NO-sintazyi: svyazs effektivnosty u tromboliticheskoy terapii u patsientov s ostryim Infarktom mIokarda]. Ukrainskiy medichniy chasopis. 2008;4(66): VII-VIII.
44. Parhomenko AN, Moybenko AA, Dosenko VE [Chastota allelnogo palimorphisma gena endotelialnoy NO-sintazy u bolnich s ostrim coronarnim sindromom v ukrainskoy populatsii]. Tsitologiya i genetika. 2005;2:49-54
45. Park K-W, You K-H, Oh S et al. Association of endothelial constitutive nitric oxide synthase gene polymorphism with acute coronary syndrome in Koreans. Heart. 2004; 90(3): 282–285.
46. Polunina OS, Ahmineeva AH, Voronina LP, Sevostyanova IV [Geneticheskie i biohimicheskie paralleli pri sochetanii hronicheskoy obstruktivnoy bolezni legkih i ishemicheskoy bolezni serdtsa]. Sibirskiy meditsinskiy zhurnal. 2013;5:54-56.
47. Rossi GP, Taddei S, Virdis A et al. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J. Am. Coll. Cardiol. 2003;41(6):938–945.
48. Rossi GP, Cesari M, Zanchetta M et al. The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol. 2003;19;41(6):930-937.
49. Rossi GP, Maiolino G, Zanchetta M et al. The T(-786)C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high-risk patients. J Am Coll Cardiol. 2006;48(6):1166-74.
50. Salimi S, Firoozrai M, Nourmohammadi I et al. Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian J Med Res. 2006;124(6):683-688.
51. Shuvalova YuA, Kaminnyiy AI, Meshkov AN et al [Polimorfizmyi genov eNOS i GPx-1 assotsiirovanyi s riskom razvitiya restenoza posle stentirovaniya koronarnyih arteriy nepokryityimi stentami]. Mezhdunarodnyiy zhurnal interventsionnoy kardiologii. 2011;25:47-53.
52. Song J, Yoon Y, Park KU et al. Genotipe-specific influence on nitric oxide synthase gene expression, protein concentration and enzyme activity in cultured human endothelial cells. Clin. Chem. 2003;49(6):847-852.
53. Song J, Yoon Y, Park KU et al. Genotype-specific influence on nitric oxide synthase gene expression, protein concen¬trations, and enzyme activityin cultured human endothelial cells. Clin. Chem. 2003;49(6 Pt 1):847–852.
54. Takagi S, Goto Y, Nonogi H et al. Genetic polymorphisms of angiotensin converting enzyme (I/D) and endothelial nitric oxide synthase (T(-788)C) genes in Japanese patients with myocardial infarction. Thromb. Haemost. 2001;86(5):1339–1340.
55. Tangurek B, Ozer N, Sayar N et al. The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population. Heart Vessels. 2006;21(5):285-90.
56. Tanus-Santos JE, Desai M, Deak LR et al. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics. 2002;12(5):407–413.
57. Tarja K Association of endothelial nitric oxide synthase and estrogen reseptor α-gene polimorphisms with coronary artery disease. Academic Dissertation. 2004. 82p.
58. Wang J, Dudley D, Wang XL Haplotype-specific effects on endothelial NO synthase promoter efficiency: Modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol. 2002;22:e1–4.
59. Wang XL, Sim AS, Badenhop RF et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med. 1996;2:41–45.
60. Xin Y, Song X, Xue H et al. A common variant of the eNOS gene (E298D) is an independent risk factor for left ventricular hypertrophy in human essential hypertension. Clin.Sci (lond).2009;15;117(2):67-73.
61. Yang Y, Du K, Liu Z, Lu X Endothelial nitric oxide synthase (eNOS) 4b/a gene polymorphisms and coronary artery disease: evidence from a meta-analysis. Int J Mol Sci. 2014;7;15(5):7987-8003.
62. Yoon Y, Song J, Hong SH, Kim JQ Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin. Chem. 2000;46(10):1626–1630.
63. Yoshimura M, Nakayama M, Shimasaki Y et al. A T-786C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene and coronary arterial vasomotility. Am. J. Cardiol. 2000;85(6):710–714.
64. Yoshimura M, Yasue H, Nakayama M et al. Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786-->C and missense Glu298Asp variants. J Investiq. Med. 2000;48(5):367-74.
65. Yujiao Y, Kang D, Zhengxia L, Xiang L Endothelial Nitric Oxide Synthase (eNOS) 4b/a Gene Polymorphisms and Coronary Artery Disease: Evidence from a Meta-Analysis. Int J Mol Sci. 2014;15(5):7987–8003.
66. Zhang K, Bai P, Shi S et al. The G894T polymorphism on endothelial nitric oxide synthase gene is associated with increased coronary heart disease among Asia population: evidence from a Meta analysis. Thromb Res. 2012;130:192–197.